Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 6, 2012, Pages 4458-4466

  Li, Linlin ^a   Huang, Xinglu ^a   Liu, Tianlong ^a   Liu, Huiyu ^a   Hao, Nanjing ^a,b   Chen, Dong ^a   Zhang, Yanqi ^a   Li, Laifeng ^a   Tang, Fangqiong ^a  

^a TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Aspect Ratio; Doxorubicin; Drug Retention; Mesoporous Silica Nanoparticles; Multidrug Resistance; Nanorod

Indexed keywords

CANCER THERAPY; CELLULAR UPTAKE; CHINESE HAMSTER OVARY CELLS; DOXORUBICIN; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG LOADING; DRUG LOADING CAPACITY; DRUG RETENTION; HUMAN MALIGNANCIES; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; MULTIDRUG RESISTANCE; NANOCARRIERS; NANOPARTICULATE DRUG DELIVERY SYSTEMS; NON-SPHERICAL; THERAPEUTIC EFFICACY;

ASPECT RATIO; CHEMOTHERAPY; DRUG DELIVERY; ENZYME INHIBITION; NANORODS;

LOADING;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; NANOCAPSULE; SILICON DIOXIDE;

ANIMAL; ARTICLE; CELL SURVIVAL; CHEMISTRY; CHO CELL; DIFFUSION; DRUG EFFECT; DRUG RESISTANCE; HAMSTER; MULTIDRUG RESISTANCE; POROSITY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL SURVIVAL; CHO CELLS; CRICETINAE; DIFFUSION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; NANOCAPSULES; POROSITY; SILICON DIOXIDE;

EID: 84863922112     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.6198     Document Type: Article

References (40)

1. M. M. Gottesman, T. Fojo, and S. E. Bates, Nat. Rev. Cancer 2, 48 (2002).
2. D. Hanahan and R. A. Weinberg, Cell 144, 646 (2011).
3. H. J. Broxterman, K. J. Gotink, and H. M. W. Verheul, Drug resist. Update 12, 114 (2009).
4. K. L. Hennenfent and R. Govindan, Ann. Oncol. 80, 735 (2006).
5. O. Trédan, C. M. Galmarini, K. Patel, and I. F. Tannock, J. Natl. Cancer I. 99, 1441 (2007).
6. D. M. Bradshaw and R. J. Arceci, J. Clin. Oncol. 16, 3674 (1998).
7. D. R. Ferry, H. Traunecker, and D. J. Kerr, Eur. J. Cancer 32A, 1070 (1996).
8. K. Ishikawa, T. Akasaka, Y. Yawaka, and F. Watari, J. Biomed. Nanotechnol. 6, 59 (2010).
9. A. Babu, K. Jeyasubramanian, P. Gunasekaran, and R. Murugesan, J. Biomed. Nanotechnol. 8, 43 (2012).
10. E. Pedziwiatr-Werbicka, D. Shcharbin, J. Maly, M. Maly, M. Zaborski, B. Gabara, P. Ortega, F. J. de la Mata, R. Gómez, M. A. Muñoz- Fernandez, B. Klajnert, and M. Bryszewska, J. Biomed. Nanotechnol. 8, 57 (2012).
11. G. D. Venkatasubbu, S. Ramasamy, V. Ramakrishnan, and J. Kumar, J. Biomed. Nanotechnol. 7, 759 (2011).
12. A. Taheri, R. Dinarvand, F. Atyabi, F. Nouri, F. Ahadi, M. H. Ghahremani, S. N. Ostad, A. T. Borougeni, and P. Mansoori, J. Biomed. Nanotechnol. 7, 743 (2011).
13. C. E. Soma, C. Dubernet, G. Barratt, F. Nemati, M. Appel, S. Benita, and P. Couvreur, Pharmacol. Res. 16, 1710 (1999).
14. A. Shapira, D. Livney Y, H. J. Broxterman, and Y. G. Assaraf, Drug Resist. Update 14, 150 (2011).
15. X. Wang, J. Li, Y. X. Wang, L. Koenig, A. Gjyrezi, P. Giannakakou, E. H. Shin, M. Tighiouart, Z. G. Chen, S. M. Nie, and D. M. Shin, ACS Nano 5, 6184 (2011).
16. Y. Lee, R. Graeser, F. Kratz, and K. E. Geckeler, Adv. Funct. Mater. 21, 4211 (2011).
17. T. Kobayashi, T. Ishida, Y. Okada, S Ise, H. Harashima, and H. Kiwada, Int. J. Pharmaceut. 329, 94 (2007).
18. H. Meng, M. Liong, T. Xia, Z. X. Li, Z. X. Ji, J. I. Zink, and A. E. Nel, ACS Nano 4, 4539 (2010).
19. S. Yadav, L. E. van Vlerken, S. R. Little, and M. M. Amiji, Cancer Chemoth. Pharm. 63, 711 (2009).
20. M. Vallet-Regi, A. Ramila, R. P. del Real, and J. Perez-Pariente, Chem. Mater. 13, 308 (2001).
21. T. L. Liu, L. L. Li, X. Teng, X. L. Huang, H. Y. Liu, D. Chen, J. Ren, J. Q. He, and F. Q. Tang, Biomaterials 32, 1657 (2011).
22. Y. Zhao, B. G. Trewyn, I. I. Slowing, and V. S. Y. Lin, J. Am. Chem. Soc. 131, 8398 (2009).
23. K. P. Singh, P. Panwar, P. Kohli, and Sanjesh, J. Biomed. Nanotechnol. 7, 60 (2011).
24. V. Lebret, L. Raehm, J. O. Durand, M. Smaihi, M. H. V. Werts, M. Blanchard-Desce, D. Méthy-Gonnod, and C. Dubernet, J. Biomed. Nanotechnol. 6, 176 (2010).
25. H. H. P. Yiu, S. C. McBain, Z. A. D. Lethbridge, M. R. Lees, I. Palona, C. I. Olariu, and J. Dobson, J. Nanosci. Nanotechnol. 11, 3586 (2011).
26. D. Chen, L. L. Li, F. Q. Tang, and S. Qi, Adv. Mater. 21, 3804 (2009).
27. L. L. Li, Y. Q. Guan, H. Y. Liu, N. J. Hao, T. L. Liu, X. W. Meng, C. H. Fu, Y. Z. Li, Q. L. Qu, Y G Zhang, S. Y. Ji, L. Chen, D. Chen, and F. Q. Tang, ACS Nano 5, 7462 (2011).
28. L. L. Li, F. Q. Tang, H. Y. Liu, T. L. Liu, N. J. Hao, D. Chen, X. Teng, and J. Q. He, ACS Nano 4, 6874 (2010).
29. A. E. Nel, L. Madler, D. Velegol, T. Xia, E. M. V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson, Nat. Mater. 8, 543 (2009).
30. R. A. Petros and J. M. DeSimone, Nat. Rev. Drug Discov. 9, 615 (2010).
31. Y. Geng, P. Dalhaimer, S. S. Cai, R. Tsai, M. Tewari, T. Minko, and D. E. Discher, Nat. Nanotechnol. 2, 249 (2007).
32. X. L. Huang, X. Teng, D. Chen, F. Q. Tang, and J. Q. He, Biomaterials 31, 438 (2010).
33. X. L. Huang, L. L. Li, T. L. Liu, N. J. Hao, H. Y. Liu, D. Chen, and F. Q. Tang, ACS Nano 5, 5390 (2011).
34. N. Kartner, M. Shales, J. R. Riordan, and V. Ling, Cancer Res. 43, 4413 (1983).
35. S. Yang, L. Z. Zhao, C. Z. Yu, X. F. Zhou, J. W. Tang, P. Yuan, D. Y. Chen, and D. Y. Zhao, J. Am. Chem. Soc. 128, 10460 (2006).
36. B. G. Trewyn, C. M. Whitman, and V. S. Y. Lin, Nano Lett. 4, 2139 (2004).
37. M. Arruebo, R. Fernandez-Pacheco, S. Irusta, J. Arbiol, M. R. Ibarra, and J. Santamaria, Nanotechnology 17, 4057 (2006).
38. T. Lebold, C. Jung, J. Michaelis, and C. Brauchle, Nano Lett. 9, 2877 (2009).
39. L. Zhang, S. Z. Qiao, Y. G. Jin, L. N. Cheng, Z. F. Yan, and G. Q. Lu, Adv. Funct. Mater. 18, 3834 (2008).
40. J. Kapuscinski, Biotech. Histochem. 70, 220 (1995).